发明名称 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
摘要 Ribavirin derivatives represented by formula I wherein at least one of R2, R3 or R5 is a straight or branched chain polyalkylene oxide polymer conjugate, and pharmaceutical compositions containing them as well as their use to treat patients having susceptible viral infections, alone and in combination with a therapeutically effective amount of interferon-alpha are disclosed.
申请公布号 US2003004119(A1) 申请公布日期 2003.01.02
申请号 US20010837609 申请日期 2001.04.18
申请人 GANGULY ASHIT K.;MCCORMICK JINPING;LOVEY RAYMOND G.;BENNETT FRANK;SAKSENA ANIL K.;GIRIJAVALLABHAN VIYYOOR M. 发明人 GANGULY ASHIT K.;MCCORMICK JINPING;LOVEY RAYMOND G.;BENNETT FRANK;SAKSENA ANIL K.;GIRIJAVALLABHAN VIYYOOR M.
分类号 A61K31/7056;A61K38/21;A61K45/06;C07H19/056;(IPC1-7):A61K31/705 主分类号 A61K31/7056
代理机构 代理人
主权项
地址
您可能感兴趣的专利